Antioxidant therapies for traumatic brain injury - PubMed (original) (raw)
Review
Antioxidant therapies for traumatic brain injury
Edward D Hall et al. Neurotherapeutics. 2010 Jan.
Abstract
Free radical-induced oxidative damage reactions, and membrane lipid peroxidation (LP), in particular, are among the best validated secondary injury mechanisms in preclinical traumatic brain injury (TBI) models. In addition to the disruption of the membrane phospholipid architecture, LP results in the formation of cytotoxic aldehyde-containing products that bind to cellular proteins and impair their normal functions. This article reviews the progress of the past three decades in regard to the preclinical discovery and attempted clinical development of antioxidant drugs designed to inhibit free radical-induced LP and its neurotoxic consequences via different mechanisms including the O(2)(*-) scavenger superoxide dismutase and the lipid peroxidation inhibitor tirilazad. In addition, various other antioxidant agents that have been shown to have efficacy in preclinical TBI models are briefly presented, such as the LP inhibitors U83836E, resveratrol, curcumin, OPC-14177, and lipoic acid; the iron chelator deferoxamine and the nitroxide-containing antioxidants, such as alpha-phenyl-tert-butyl nitrone and tempol. A relatively new antioxidant mechanistic strategy for acute TBI is aimed at the scavenging of aldehydic LP byproducts that are highly neurotoxic with "carbonyl scavenging" compounds. Finally, it is proposed that the most effective approach to interrupt posttraumatic oxidative brain damage after TBI might involve the combined treatment with mechanistically complementary antioxidants that simultaneously scavenge LP-initiating free radicals, inhibit LP propagation, and lastly remove neurotoxic LP byproducts.
Copyright 2010 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
- Newer pharmacological approaches for antioxidant neuroprotection in traumatic brain injury.
Hall ED, Wang JA, Miller DM, Cebak JE, Hill RL. Hall ED, et al. Neuropharmacology. 2019 Feb;145(Pt B):247-258. doi: 10.1016/j.neuropharm.2018.08.005. Epub 2018 Aug 4. Neuropharmacology. 2019. PMID: 30086292 Review. - Antioxidant therapies in traumatic brain and spinal cord injury.
Bains M, Hall ED. Bains M, et al. Biochim Biophys Acta. 2012 May;1822(5):675-84. doi: 10.1016/j.bbadis.2011.10.017. Epub 2011 Nov 4. Biochim Biophys Acta. 2012. PMID: 22080976 Free PMC article. Review. - Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice.
Miller DM, Singh IN, Wang JA, Hall ED. Miller DM, et al. Exp Neurol. 2015 Feb;264:103-10. doi: 10.1016/j.expneurol.2014.11.008. Epub 2014 Nov 26. Exp Neurol. 2015. PMID: 25432068 Free PMC article. - Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.
Fernández-Gajardo R, Matamala JM, Carrasco R, Gutiérrez R, Melo R, Rodrigo R. Fernández-Gajardo R, et al. CNS Drugs. 2014 Mar;28(3):229-48. doi: 10.1007/s40263-013-0138-y. CNS Drugs. 2014. PMID: 24532027 Review.
Cited by
- Hydrogel in the Treatment of Traumatic Brain Injury.
Li S, Xu J, Qian Y, Zhang R. Li S, et al. Biomater Res. 2024 Sep 26;28:0085. doi: 10.34133/bmr.0085. eCollection 2024. Biomater Res. 2024. PMID: 39328790 Free PMC article. Review. - Oxidative stress in the brain-lung crosstalk: cellular and molecular perspectives.
Kong J, Fan R, Zhang Y, Jia Z, Zhang J, Pan H, Wang Q. Kong J, et al. Front Aging Neurosci. 2024 Apr 3;16:1389454. doi: 10.3389/fnagi.2024.1389454. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38633980 Free PMC article. Review. - Mitochondria-Targeted Antioxidant Therapeutics for Traumatic Brain Injury.
Modi HR, Musyaju S, Ratcliffe M, Shear DA, Scultetus AH, Pandya JD. Modi HR, et al. Antioxidants (Basel). 2024 Feb 29;13(3):303. doi: 10.3390/antiox13030303. Antioxidants (Basel). 2024. PMID: 38539837 Free PMC article. Review. - Engineered Dual Antioxidant Enzyme Complexes Targeting ICAM-1 on Brain Endothelium Reduce Brain Injury-Associated Neuroinflammation.
Leonard BM, Shuvaev VV, Bullock TA, Galpayage Dona KNU, Muzykantov VR, Andrews AM, Ramirez SH. Leonard BM, et al. Bioengineering (Basel). 2024 Feb 21;11(3):200. doi: 10.3390/bioengineering11030200. Bioengineering (Basel). 2024. PMID: 38534474 Free PMC article. - Pomalidomide Improves Motor Behavioral Deficits and Protects Cerebral Cortex and Striatum Against Neurodegeneration Through a Reduction of Oxidative/Nitrosative Damages and Neuroinflammation After Traumatic Brain Injury.
Huang YN, Greig NH, Huang PS, Chiang YH, Hoffer A, Yang CH, Tweedie D, Chen Y, Ou JC, Wang JY. Huang YN, et al. Cell Transplant. 2024 Jan-Dec;33:9636897241237049. doi: 10.1177/09636897241237049. Cell Transplant. 2024. PMID: 38483119 Free PMC article.
References
- Kontos HA, Povlishock JT. Oxygen radicals in brain injury. Cent Nerv Syst Trauma. 1986;3:257–263. - PubMed
- Halliwell B, Gutteridge JMC. Free Radicals in biology and medicine. 3rd ed. Oxford: Oxford University Press; 2008.
- Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW. Hemoglobin. A biologic fenton reagent. J Biol Chem. 1984;259:14354–14356. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS046566-04/NS/NINDS NIH HHS/United States
- R01 NS046566-02/NS/NINDS NIH HHS/United States
- R01 NS046566-01A1/NS/NINDS NIH HHS/United States
- 5R01 NS046566/NS/NINDS NIH HHS/United States
- R01 NS046566/NS/NINDS NIH HHS/United States
- P30 NS051220-04/NS/NINDS NIH HHS/United States
- P30 NS051220-01/NS/NINDS NIH HHS/United States
- P30 NS051220-05/NS/NINDS NIH HHS/United States
- P30 NS051220-02/NS/NINDS NIH HHS/United States
- 5P30NS051220/NS/NINDS NIH HHS/United States
- P30 NS051220/NS/NINDS NIH HHS/United States
- P30 NS051220-03/NS/NINDS NIH HHS/United States
- R01 NS046566-03/NS/NINDS NIH HHS/United States
- 5P01 NS58484/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous